Additionally, increased SCARA3 mRNA expression was observed in a myeloma cell line, MM.IS, treated with the DNA methyltransferase inhibitor aza-dC, indicating epigenetic regulation. The gene discussed is SCARA3; the disease is Miyoshi myopathy.